Application 077665
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | TABLET;ORAL | EQ 75MG BASE | No | No |
| 002 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | TABLET;ORAL | EQ 300MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077665-001 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | ||
| A077665-002 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | AB | 2012-05-17 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | AB | 2012-05-17 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A077665-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-05-17 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A077665-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-05-17 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-09-15 20:21 UTC | 2019-09 | A077665-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077665-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clopidogrel | CLOPIDOGREL BISULFATE | Westminster Pharmaceuticals, LLC | bb3b5e96-e629-4db5-8ad5-40c17c6dae18 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 669f0bc6-f173-484d-8efe-c006683b25d1 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 2969deac-274b-4042-9c90-9522e62a979d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals Inc. | c9928956-bb7b-4ec2-bc38-d3c9c4199cae | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 3e2539c1-a6ad-4d60-944c-c2e7aa70ce45 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | e5ee3807-5c9d-4b65-b188-4159a0fb1c85 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Ascend Laboratories, LLC | db1161c9-6efd-4361-a766-6a37c241ccee | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Cardinal Health 107, LLC | c03a895c-2d74-4d7f-891f-b752ce409b68 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals, Inc. | e51d4bcc-01df-409d-9179-45e6536ac25b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Legacy Pharmaceutical Packaging, LLC | 53de10a5-dbd0-413d-90e5-00a1920ec391 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 553b4938-4462-4aeb-e054-00144ff88e88 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 55530ff3-5ce4-120f-e054-00144ff8d46c | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | 8406b8e3-e203-402f-8858-2748119e2351 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | AvPAK | 94a5cdc4-e063-1d46-e053-2995a90a7e15 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Novadoz Pharmaceuticals LLC | 1447a095-c663-4f05-91d4-f09bfc0c3d42 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | d072b6ea-2bb4-8965-918e-23f9080efcb0 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | 333c7992-d481-b7d4-404f-9a49c85b6331 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Apotex Corp. | edae8df1-caf9-ff72-1304-5ae8b355f8e7 | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Major Pharmaceuticals | 4cd07a3c-9673-4aa0-b76a-d79df2399ee1 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Dr.Reddy's Laboratories Limited | b5aa951f-72de-bea1-98a2-a4085c64a361 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-3627 | Clopidogrel Bisulfate | clopidogrel | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3627 | Clopidogrel Bisulfate | clopidogrel | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 51079-558 | Clopidogrel Bisulfate | clopidogrel | Mylan Institutional Inc. | ANDA | Current |
| 55154-5388 | Clopidogrel Bisulfate | clopidogrel | Cardinal Health | ANDA | Current |
| 55154-5388 | Clopidogrel Bisulfate | clopidogrel | Cardinal Health | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9074 | ORIG | 2012-05-18 |